COMPARATIVE BIOAVAILABILITY STUDY OF TWO MYCOPHENOLATE MOFETIL FORMULATIONS IN STABLE KIDNEY TRANSPLANT RECIPIENTS

被引：0

作者：

Sunder-Plassmann, Gere ^{[1
]}

Reinke, Petra ^{[2
]}

Rath, Thomas ^{[3
]}

Wiecek, Andrzej ^{[4
]}

Nowicki, Michal ^{[5
]}

Moore, Richard ^{[6
]}

Lutz, Jens ^{[7
]}

Gaggl, Martina ^{[1
]}

Ferkl, Marek ^{[8
]}

机构：

[1] Med Univ Vienna, Dept Med 3, Vienna, Austria

[2] Univ Hosp Charite, Dept Nephrol & Intens Care Med, Berlin, Germany

[3] Westpfalz Klinikum GmbH, Dept Nephrol & Transplantat, Kaiserslautern, Germany

[4] Med Univ Silesia, Dept Nephrol Endocrinol & Metab Dis, Katowice, Poland

[5] Med Univ Lodz, Dept Nephrol Hypertens & Kidney Transplantat, Lodz, Poland

[6] Univ Wales Hosp, Dept Nephrol & Transplant, Cardiff CF4 4XW, S Glam, Wales

[7] Univ Hosp Rechts der Isar, Dept Nephrol, Munich, Germany

[8] Teva Pharmaceut Europe, Med Affairs, Harlow, Essex, England

来源：

TRANSPLANT INTERNATIONAL | 2011年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

引用

页码：81 / 81

页数：1

共 50 条

[21] Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil - A prospective randomized study
Ahsan, N
Hricik, D
Matas, A
Rose, S
Tomlanovich, S
Wilkinson, A
Ewell, M
McIntosh, M
Stablein, D
Hodge, E
Hayes, D
Gores, P
Cohen, D
Gonwa, T
Brinler, K
Harland, R
Neylan, J
Pescovitz, M
Wynn, J
Ahsan, N
Yang, HC
Bennett, W
Copley, J
Wilkinson, A
Dunn, J
Tomlanovich, S
Chan, L
Bertolatus, JA
Weir, M
Mendez, R
Pirsch, J
Helderman, JH
[J]. TRANSPLANTATION, 1999, 68 (12) : 1865 - 1874
[22] Results of a Comparative Bioavailability Study of Myfenax® (Teva) and CellCeptw® (Roche) in Stable Kidney Transplant Recipients
Sunder-Plassmann, G.
Reinke, P.
Rath, T.
Wiecek, A.
Nowicki, M.
Moore, R.
Gaggl, M.
Ferkl, M.
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 351 - 352
[23] The use of mycophenolate mofetil in transplant recipients
Mele, TS
Halloran, PF
[J]. IMMUNOPHARMACOLOGY, 2000, 47 (2-3): : 215 - 245
[24] Cyclosporin changes the pharmacokinetics of mycophenolate mofetil in kidney transplant recipients.
Gregoor, PJHS
Hesse, CJ
van der Mast, BJ
IJzermans, JNM
Weimar, W
van Gelder, T
[J]. KIDNEY INTERNATIONAL, 1999, 55 (03) : 1164 - 1164
[25] Conversion to mycophenolate mofetil (MMF) in pediatric kidney transplant recipients.
Machado, PGP
Nogueira, PCK
Park, SI
Tedesco-Silva, H
Pestana, JOM
[J]. PEDIATRIC TRANSPLANTATION, 2005, 9 : 92 - 92
[26] Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen in stable kidney transplant recipients: A randomized, controlled study
Abramowicz, D
Manas, D
Lao, M
Vanrenterghem, Y
del Castillo, D
Wijngaard, P
Fung, S
[J]. TRANSPLANTATION, 2002, 74 (12) : 1725 - 1734
[27] Variability of mycophenolate mofetil trough levels in stable kidney transplant patients
Fernandez, A.
Martins, J.
Villlafruela, J. J.
Marcen, R.
Pascual, J.
Cano, T.
Puig, C.
Gil-Casares, B.
Muriel, A.
Burgos, F. J.
Ortuno, J.
[J]. TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) : 2185 - 2186
[28] Prevalence of Mycophenolate Mofetil discontinuation and subsequent outcomes in pediatric kidney transplant recipients: A PNRC study
Moudgil, Asha
Sgambat, Kristen
Benoit, Elizabeth
Seifert, Michael
Bharadwaj, Madhumithaa
Jain, Amrish
Mansuri, Asif
Harshman, Lyndsay
Katsoufis, Chryso
Somers, Michael
[J]. PEDIATRIC TRANSPLANTATION, 2022, 26
[29] Pharmacokinetic study of mycophenolate mofetil in Asian renal transplant recipients
Yeung, S
Tong, KL
Tsang, WK
Chan, HWH
Chan, AYW
[J]. TRANSPLANTATION PROCEEDINGS, 2000, 32 (07) : 1753 - 1754
[30] Prevalence of mycophenolate mofetil discontinuation and subsequent outcomes in pediatric kidney transplant recipients: A PNRC study
Moudgil, Asha
Sgambat, Kristen
Benoit, Elizabeth
Seifert, Michael E.
Bharadwaj, Madhumithaa
Jain, Amrish
Mansuri, Asif
Harshman, Lyndsay
Katsoufis, Chryso
Somers, Michael
[J]. PEDIATRIC TRANSPLANTATION, 2024, 28 (01)

← 1 2 3 4 5 →